GENUARDI, MAURIZIO
 Distribuzione geografica
Continente #
NA - Nord America 10.946
EU - Europa 5.482
AS - Asia 3.578
SA - Sud America 442
AF - Africa 128
OC - Oceania 95
Continente sconosciuto - Info sul continente non disponibili 42
Totale 20.713
Nazione #
US - Stati Uniti d'America 10.814
RU - Federazione Russa 1.816
SG - Singapore 1.089
IT - Italia 1.083
CN - Cina 767
IE - Irlanda 578
HK - Hong Kong 567
PL - Polonia 480
SE - Svezia 458
VN - Vietnam 370
BR - Brasile 368
KR - Corea 349
DE - Germania 257
UA - Ucraina 257
FI - Finlandia 193
FR - Francia 156
GB - Regno Unito 116
IN - India 116
AU - Australia 94
TR - Turchia 87
CA - Canada 74
BD - Bangladesh 55
JP - Giappone 45
CI - Costa d'Avorio 39
JO - Giordania 31
AR - Argentina 28
MX - Messico 26
CH - Svizzera 23
NG - Nigeria 20
ZA - Sudafrica 16
IQ - Iraq 14
NL - Olanda 14
ID - Indonesia 11
SC - Seychelles 10
CO - Colombia 9
EC - Ecuador 9
MA - Marocco 9
PK - Pakistan 9
UZ - Uzbekistan 9
ES - Italia 8
MY - Malesia 8
VE - Venezuela 8
AZ - Azerbaigian 7
HN - Honduras 7
AE - Emirati Arabi Uniti 6
BE - Belgio 6
EG - Egitto 6
JM - Giamaica 6
SA - Arabia Saudita 6
SN - Senegal 6
CL - Cile 5
CZ - Repubblica Ceca 5
IL - Israele 5
LT - Lituania 5
PH - Filippine 5
PY - Paraguay 5
TN - Tunisia 5
UY - Uruguay 5
AT - Austria 4
DO - Repubblica Dominicana 4
KE - Kenya 4
TH - Thailandia 4
TT - Trinidad e Tobago 4
AL - Albania 3
BJ - Benin 3
DK - Danimarca 3
ET - Etiopia 3
EU - Europa 3
GE - Georgia 3
GR - Grecia 3
NP - Nepal 3
OM - Oman 3
PE - Perù 3
AO - Angola 2
BO - Bolivia 2
BS - Bahamas 2
DZ - Algeria 2
EE - Estonia 2
KZ - Kazakistan 2
MD - Moldavia 2
NO - Norvegia 2
PA - Panama 2
PR - Porto Rico 2
PS - Palestinian Territory 2
RS - Serbia 2
TW - Taiwan 2
AD - Andorra 1
AW - Aruba 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CM - Camerun 1
CR - Costa Rica 1
CW - ???statistics.table.value.countryCode.CW??? 1
GT - Guatemala 1
HU - Ungheria 1
LB - Libano 1
LV - Lettonia 1
LY - Libia 1
MU - Mauritius 1
Totale 20.670
Città #
Santa Clara 1.831
Fairfield 1.295
Ashburn 1.151
Singapore 759
Dublin 577
Woodbridge 574
Chandler 545
Seattle 545
Cambridge 513
Warsaw 480
Houston 438
Hong Kong 429
Jacksonville 410
Wilmington 406
Seoul 348
San Jose 340
Milan 241
Beijing 239
Ann Arbor 156
Los Angeles 153
Princeton 146
The Dalles 133
Ho Chi Minh City 118
Lauterbourg 117
Boardman 110
Hefei 105
Buffalo 101
Florence 95
Rome 95
Boston 93
Melbourne 92
Hanoi 91
Mumbai 82
Medford 80
Izmir 76
Lawrence 68
Moscow 63
Munich 59
New York 56
Dallas 51
Altamura 50
San Diego 50
Tokyo 44
Abidjan 39
Norwalk 39
Shanghai 36
Turin 31
São Paulo 29
Bologna 27
Kent 26
Chicago 25
Council Bluffs 24
Helsinki 24
Turku 24
Naples 22
Abuja 20
Bern 20
Haiphong 20
Toronto 20
Frankfurt am Main 19
Brooklyn 17
Da Nang 17
Figino 17
Andover 16
Paris 16
Redondo Beach 15
Rio de Janeiro 15
Hillsboro 14
London 14
Orem 14
Verona 14
Frankfurt Am Main 13
Palermo 13
Bari 12
Falls Church 12
Mexico City 12
Atlanta 10
Latina 10
Montreal 10
Chennai 9
Phoenix 9
Yubileyny 9
Bremen 8
Dong Ket 8
Johannesburg 8
Perugia 8
Baku 7
Berlin 7
Brescia 7
Newark 7
Padua 7
San Francisco 7
Auburn Hills 6
Biên Hòa 6
Brussels 6
Catania 6
Dakar 6
Genoa 6
Guangzhou 6
Jakarta 6
Totale 14.260
Nome #
Genetica umana e medica 334
Lone and secondary nonvalvular atrial fibrillation: role of a genetic susceptibility 289
X-linked VACTERL with hydrocephalus: the VACTERL-H syndrome. 279
A mononucleotide markers panel to identify hMLH1/hMSH2 germline mutations. 274
Fatal Malonyl CoA Decarboxylase Deficiency Due to Maternal Uniparental Isodisomy of the Telomeric End of Chromosome 16 256
Identification of a BRCA2-specific modifier locus at 6p24 related to breast cancer risk. 253
Anti-miR21 oligonucleotide enhances chemosensitivity of T98G cell line to doxorubicin by inducing apoptosis. 229
Stability of BAT26 in tumours of hereditary nonpolyposis colorectal cancer patients with MSH2 intragenic deletion. 223
A rare combination consisting of aldosterone-producing adenoma and adrenal myelolipoma in a patient with heterozygosity for retinoblastoma (RB) gene. 202
Activating PTPN11 mutations play a minor role in pediatric and adult solid tumors. 200
A novel microdeletion syndrome with loss of the MSH2 locus and hereditary non-polyposis colorectal cancer. 199
Susceptibility to refractory ulcerative colitis is associated with polymorphism in the hMLH1 mismatch repair gene. 197
Founder mutations account for the majority of BRCA1-attributable hereditary breast/ovarian cancer cases in a population from Tuscany, Central Italy. 196
Bone density and metabolism in subjects with microdeletion of chromosome 22q11 (del22q11) 195
Thyroid function and morphology in subjects with microdeletion of chromosome 22q11 (del(22)(q11)). 189
A kindred with MYH-associated polyposis and pilomatricomas. 186
The p.G23S CDKN2A founder mutation in high-risk melanoma families from Central Italy. 180
Phenotype variability of neural crest-derived tumours in six Italian families segregating the same founder SDHD mutation Q109X. 178
NF2 mutation screening by denaturing high-performance liquid chromatography and high-resolution melting analysis. 178
Aetiology of colorectal cancer and relevance of monogenic inheritance 178
Correlation between thymidylate synthase (TS) mRNA expression and TS gene promoter polymorphisms in primary colorectal cancer patients 178
A genetic model for determining MSH2 and MLH1 carrier probabilities based on family history and tumor microsatellite instability 173
A proteomics approach to identify changes in protein profiles in serum of Familial Adenomatous Polyposis patients 173
Analysis of 138 consecutive ovarian cancer patients: incidence and characteristics of familial cases. 173
Mosaic trisomy 17 in amniocytes: phenotypic outcome, tissue distribution, and uniparental disomy studies. 173
Duodenal carcinoma in a 37-year-old man with Cowden/Bannayan syndrome. 172
Novel TMEM67 mutations and genotype-phenotype correlates in meckelin-related ciliopathies. 172
A split hand-split foot (SHFM3) gene is located at 10q24-->25. 171
A girl with G syndrome and agenesis of the corpus callosum. 169
The clinical role of PIK3CA mutations in colorectal cancer 168
Assessment of pathogenicity criteria for constitutional missense mutations of the hereditary nonpolyposis colorectal cancer genes MLH1 and MSH2 168
Frequency of constitutional MSH6 mutations in a consecutive series of families with clinical suspicion of HNPCC 168
Simple and complex genetics of colorectal cancer susceptibility 168
Endometrial cancer and somatic G>T KRAS transversion in patients with constitutional MUTYH biallelic mutations. 165
A new point mutation of the prion protein gene in Creutzfeldt-Jakob disease. 164
Split hand/split foot anomaly in a family segregating a balanced translocation with breakpoint on 7q22.1. 162
Alterazioni somatiche del gene kras in pazienti con mutazioni mono e bialleliche di MUTYH. 162
Cancer risk in hereditary nonpolyposis colorectal cancer due to MSH6 mutations: Impact on counseling and surveillance 161
Molecular genetic alterations and clinical features in early-onset colorectal carcinomas and their role for the recognition of hereditary cancer syndromes 160
MLH1 constitutional and somatic methylation in patients with MLH1 negative tumors fulfilling the revised Bethesda criteria. 158
Evidence of a four-hit mechanism involving SMARCB1 and NF2 in schwannomatosis-associated schwannomas. 157
Split hand/split foot, syndactyly, urinary tract obstruction, radial, diaphragmatic, and neural tube defects: Czeizel-Losonci syndrome? 156
A new case of interstitial deletion of chromosome 3q, del(3q)(q13.12q21.3), with agenesis of the corpus callosum. 153
Cerebro-reno-digital (Meckel-like) syndrome with Dandy-Walker malformation, cystic kidneys, hepatic fibrosis, and polydactyly. 153
Cancer risk associated with STK11/LKB1 germline mutations in Peutz-Jeghers syndrome patients: results of an Italian multicenter study. 153
Two novel mutations and a new STK11/LKB1 gene isoform in Peutz-Jeghers patients. 152
Problems in the identification of hereditary nonpolyposis colorectal cancer in two families with late development of full-blown clinical spectrum. 152
A single mutation in the FGA locus responsible for false homozygosities and discrepancies between commercial kits in an unusual paternity test case 151
Expression of GLI-1 and cytoplasmic and secretory proteins in a human basal keratinocyte cell line. 151
Microsatellite instability is not related to response to cisplatin-based chemotherapy in cervical cancer. 150
Stepwise functional assessment of unclassified DNA variants. 149
Genetic profiling of Bolivian population using 15 STR markers of forensic importance. 149
Ulnar ray defect in an infant with a 6q21;7q31.2 translocation: further evidence for the existence of a limb defect gene in 6q21. 148
Malignant extra-adrenal pheochromocytoma caused by an SDHB intronic variation leading to a 54-bp deletion in exon 4. 148
A founder MLH1 mutation in hereditary non polyposis colorectal cancer families from the districts of Modena and Reggio-Emilia in Northern Italy associated with protein elongation and instability 147
Biphasic kinetics of the human DNA repair protein MED1 (MBD4), a mismatch-specific DNA N-glycosylase 145
Gene for Simpson-Golabi-Behmel syndrome is linked to HPRT in Xq26 in two European families. 145
Correlation between thymidylate synthase (TS) mRNA expression and TS gene promoter polymorphysms in primary colorectal cancer patients. 145
Thymidylate synthase and orotate phosphoribosyl-transferase gene expression and genotype as predictors for clinical outcome in colorectal cancer patients treated with 5-fluorouracil 144
Correlation between thymidylate synthase (TS) mRNA expression and TS gene promoter polymorphisms in primary colorectal cancer patients 143
First report of t(8;21)(q22;q22) in a case of de novo acute monoblastic leukemia. 143
Recommendations for genetic counseling of familial adenomatous polyposis. 142
Relationships between promoter polymorphisms in the thymidylate synthase gene and mRNA levels in colorectal cancers 141
Genomic rearrangements of the CDKN2A locus are infrequent in Italian malignant melanoma families without evidence of CDKN2A/CDK4 point mutations. 141
Characterization of MLH1 and MSH2 alternative splicing and its relevance to molecular testing of colorectal cancer susceptibility 140
Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test results. 140
Update of penetrance estimates in Birt-Hogg-Dubé syndrome 139
Fragile X founder chromosomes in Italy: a few initial events and possible explanation for their heterogeneity. 138
Hereditary nonpolyposis colorectal cancer and related conditions 138
Association between cyclin D1 (CCND1) gene amplification and human papillomavirus infection in human laryngeal squamous cell carcinoma. 137
The growing complexity of the intestinal polyposis syndromes. 137
The CFC syndrome--report of the first two cases outside the United States. 137
Genes for split hand/split foot and laterality defects on 7q22.1 and Xq24-q27.1. 136
Gene variants of unknown clinical significance in Lynch syndrome. An introduction for clinicians. 136
The use of microsatellite instability, immunohistochemistry and other variables in determining the clinical significance of MLH1 and MSH2 unclassified Variants in Lynch syndrome 135
Hereditary nonpolyposis colorectal cancer: review of clinical, molecular genetics, and counseling aspects. 134
Planning the human variome project: the Spain report. 134
Differential expression of FRA16B in peripheral lymphocytes and bone marrow cells. 134
Dosage analysis at the CSF1 and CSF1R loci in a new case of partial trisomy 5q. 134
MED1, a novel human methyl-CpG-binding endonuclease, interacts with DNA mismatch repair protein MLH1 133
Heterogeneous distribution of GLI-1 expression in basal carcinoma cells. 133
Limb-pelvis hypoplasia/aplasia: a discrete entity in the fibuloulnar developmental field complex. 132
The policy of public health genomics in Italy. 132
Microsatellite instability is an independent indicator of recurrence in sporadic stage I-II endometrial adenocarcinoma. 131
CDKN2A germline splicing mutation affecting both P16ink4 and P14arf RNA processing in a melanoma/neurofibroma kindred 130
Clinical utility gene card for: MUTYH-associated polyposis (MAP), autosomal recessive colorectal adenomatous polyposis, multiple colorectal adenomas, multiple adenomatous polyps (MAP) - update 2012. 130
BRCA1-related malignancies in a family presenting with von Recklinghausen's disease. 130
Molecular screening for hereditary nonpolyposis colorectal cancer: a prospective, population-based study 128
Oral-facial-skeletal syndromes. 128
Polymorphisms of the prion protein gene in Italian patients with Creutzfeldt-Jakob disease. 128
Genetic STRs variation in a large population from Tuscany (Italy) 127
Constitutional trisomy 8 and myelodysplasia: report of a case and review of the literature. 127
Lack of PMS2 gene-truncating mutations in patients with hereditary colorectal cancer. 126
Prognostic relevance of MLH1 and MSH2 mutations in hereditary non-polyposis colorectal cancer patients. 126
Genetic counseling in hereditary non-polyposis colorectal cancer. 125
Four novel MSH2 and MLH1 frameshift mutations and occurrence of a breast cancer phenocopy in hereditary nonpolyposis colorectal cancer 124
Encomium: Giovanni Neri-Polyhedral and down-to-earth mentor. 124
Inherited cancer predisposition 123
Consequences of modulating GLI-1 expression in a basal carcinoma cell line. 122
Thymidylate Synthase (TS) mRNA expression and TS gene promoter polymorphism in primary colorectal cancer (CRC) patients (PTS) receiving post-operative fluorouracil (5-FU)-based chemotherapy (CT) 122
Totale 16.061
Categoria #
all - tutte 54.922
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 54.922


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022808 0 82 40 37 49 49 42 58 66 34 112 239
2022/20232.151 257 203 82 155 225 434 295 146 219 8 75 52
2023/2024822 35 92 158 43 47 136 17 219 4 18 27 26
2024/20254.952 161 552 314 723 1.509 714 83 146 288 154 171 137
2025/20265.623 629 832 405 342 541 214 855 263 360 311 138 733
2026/2027196 170 26 0 0 0 0 0 0 0 0 0 0
Totale 20.713